Cite
HARVARD Citation
Zhang, L. et al. (2014). MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice. Autoimmunity. pp. 341-350. [Online].